أصول متداولة تغيير تاريخ
AbbVie USD 33.53B 4.47B 2026-03
Align Technology USD 2.66B 7.62M 2026-06
Bayer EUR 35.3B 2.39B 2026-03
Bristol-Myers Squibb USD 28.58B 1.37B 2026-06
Charles River Laboratories USD 1.49B 41.76M 2026-03
Coherus Biosciences USD 206.71M 254.25M 2025-12
Dentsply International USD 1.85B 178M 2026-03
Eli Lilly USD 54.84B 794M 2026-03
Henry Schein USD 4.5B 32M 2026-03
Idexx Laboratories USD 1.45B 40.25M 2026-03
Illumina USD 2.83B 96M 2026-06
IQVIA Holdings USD 6.23B 6M 2026-06
J&J USD 59.77B 601M 2026-06
Laboratory Of America USD 3.81B 743.9M 2026-06
Merck USD 35.02B 8.5B 2026-03
Neogen USD 604.6M 14.6M 2026-03
Pacira USD 514.96M 33.01M 2026-03
Perrigo USD 2.71B 85M 2026-03
Pfizer USD 42.82B 76M 2026-03
Phibro Animal Health USD 894.07M 31.88M 2026-03
Quest Diagnostics USD 2.84B 278M 2026-06
Sanofi EUR 31.52B 1.36B 2026-06
Sanofi EUR 30.16B 789M 2026-03
Zoetis USD 6.47B 294M 2026-03